PHARMA NASIR

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": true,
    "seat_change": false,
    "object_change": true,
    "effective_date": "2025-10-28",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0651.586.018",
    "name_full": "PHARMA NASIR",
    "legal_form": "SRL"
  },
  "signature_regime": "solo",
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "stage": "completed",
  "notary": {
    "name": "Val\u00E9rie BRUYAUX",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2023-11-09",
    "filing_date": "2023-08-24",
    "act_kind_objet": "FUSION PAR ABSORPTION - PHARMA NASIR (soci\u00E9t\u00E9 absorbante) -"
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2023-10-18",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": {
    "summary": "La soci\u00E9t\u00E9 absorb\u00E9e et la soci\u00E9t\u00E9 absorbante ont convenu que tous les actionnaires renoncent \u00E0 l\u0027\u00E9tablissement d\u0027un \u00E9tat comptable interm\u00E9diaire.",
    "articles": [
      "12:51 \u00A72"
    ]
  },
  "restructuring": {
    "parties": [
      {
        "kbo": "0651.586.018",
        "name": "PHARMA NASIR",
        "role": "acquiring",
        "address": "1050 Ixelles, Chauss\u00E9e de Boondael 182",
        "is_foreign": false,
        "legal_form": "SRL",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0425.132.885",
        "name": "APOTEEK DE PAUW",
        "role": "absorbed",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:50",
      "12:51",
      "12:52",
      "12:53",
      "12:57",
      "39"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2023-04-01",
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "L\u0027int\u00E9gralit\u00E9 du patrimoine actif et passif de la soci\u00E9t\u00E9 absorb\u00E9e, APOTEEK DE PAUW, est transf\u00E9r\u00E9 \u00E0 la soci\u00E9t\u00E9 absorbante, PHARMA NASIR.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2023-11-01"
  },
  "subject_company": {
    "kbo": "0651.586.018",
    "name_full": "PHARMA NASIR",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Val\u00E9rie BRUYAUX",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire des actionnaires de PHARMA NASIR a approuv\u00E9 la fusion par absorption de la soci\u00E9t\u00E9 APOTEEK DE PAUW. Le patrimoine entier de APOTEEK DE PAUW est transf\u00E9r\u00E9 \u00E0 PHARMA NASIR, qui sera dissoute sans liquidation. L\u0027op\u00E9ration est r\u00E9put\u00E9e avoir eu lieu le 1er novembre 2023.",
  "co_filed_documents": [
    "Urie exp\u00E9dition",
    "Statuts"
  ],
  "detected_real_type": "fusion_completed",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Ixelles",
        "region": "Brussels",
        "street": "Chauss\u00E9e de Boondael",
        "country": "BE",
        "postcode": "1050",
        "box_number": null,
        "street_number": "182"
      },
      "old_address": {
        "city": "Bruxelles",
        "region": "Brussels",
        "street": "Chauss\u00E9e de Wavre",
        "country": "BE",
        "postcode": "1050",
        "box_number": null,
        "street_number": "120"
      },
      "effective_date": "2017-12-01",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire tenue le 1er d\u00E9cembre 2017 d\u00E9cide de transf\u00E9rer le si\u00E8ge social de la soci\u00E9t\u00E9, \u00E0 partir de ce jour \u00E0 l\u0027adresse suivante: chauss\u00E9e de Boondael 182 \u00E0 1050 Ixelles."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0651.586.018",
    "name_full": "PHARMA NASIR",
    "legal_form": "SPRL"
  }
}

{
  "kind": "oprichting",
  "seat": "1050 Ixelles, chauss\u00E9e de Wavre 120",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": "1987-11-19",
        "name": "Madame NASIR Sahra Chaudhry",
        "niss": null,
        "address": "1050 Ixelles, chauss\u00E9e de Wavre 120"
      },
      "share_class": "Ordinary",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 18600.0,
      "holder_person_name": "Madame NASIR Sahra Chaudhry",
      "is_subscriber_only": false,
      "n_shares_subscribed": 100,
      "amount_subscribed_eur": 18600.0,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 18600.0,
  "subject_company": {
    "kbo": "0651.586.018",
    "name_full": "PHARMA NASIR",
    "legal_form": "SNC"
  },
  "initial_directors": [],
  "incorporation_date": "2016-04-04",
  "post_incorporation_mandates": []
}